Zenotech Laboratories Ltd Financials
Company Logo

Zenotech Laboratories Ltd Financial Statement

Zenotech Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue12.62
Operating Expense7.71
Net Profit1.23
Net Profit Margin9.75
Earning Per Share0.20
EBIDTA5.45
Effective Tax Rate50.71

Zenotech Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual40.83
Operating Expenses Annual23.61
Operating Profit Annual18.23
Interest AnnualTBA
Depreciation7.09
Net Profit Annual8.30
Tax Annual2.84

Zenotech Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning11.14
Cash Flow from Operations11.82
Cash Flow from Investing-21.15
Cash Flow from FinancingTBA
Cash Flow at the End1.82

Zenotech Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)44.65
PBIT Margin (%)27.28
PBT Margin (%)27.28
Net PROFIT Margin (%)20.33
Return On Networth / Equity (%)3.07
Return On Networth /Employed (%)4.09
Return On Assets (%)9.35
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.46

Zenotech Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual65.58
Total Current Assets Annual26.16
Non Current Assets Annual80.04
Total Shareholders Funds Annual90.54
Total Assets Annual106.21

Zenotech Laboratories Ltd Earning Calls

No Data Availabe

FAQS on Zenotech Laboratories Ltd Financials

As of May 25, 2025, Zenotech Laboratories Ltd has a market capitalization of 316.87 Cr. Value Research classifies it as a Small-Cap company.

Yes, Zenotech Laboratories Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , Zenotech Laboratories Ltd recorded a total revenue of approximately 38.98 Cr marking a significant milestone in the company's financial performance.

Zenotech Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and 0.0% annually, respectively..

Zenotech Laboratories Ltd's current PE ratio is 56.48.

Zenotech Laboratories Ltd's ROCE averaged 12.9% from the FY ending March 2023 to 2025, with a median of 12.2%. It peaked at 17.6% in March 2023, reflecting strong capital efficiency over the period..

Zenotech Laboratories Ltd's latest EBIT is Rs. 10.69 Cr, surpassing the average EBIT of Rs. 12.15 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions